Survival impact and predictive factors of axillary recurrence after sentinel biopsy.

Date publication

mai 2016

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr FRAISSE Jean

Tous les auteurs :
Houvenaeghel G, Classe JM, Garbay JR, Giard S, Cohen M, Faure C, Charytansky H, Rouzier R, Daraï E, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Fraisse J, Dravet F, Chauvet MP, Goncalves A, Lambaudie E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26971077

Résumé

The rate of axillary recurrence (AR) after sentinel lymph node biopsy is usually low but few studies investigated its impact on survival. Our aim was to determine the rate and predictive factors of AR in a large cohort of breast cancer patients and its impact on survival.

Mots clés

Adult, Aged, Axilla, Biomarkers, Tumor, analysis, Breast Neoplasms, chemistry, Chemotherapy, Adjuvant, Female, France, Humans, Immunohistochemistry, Kaplan-Meier Estimate, Lymph Nodes, chemistry, Lymphatic Metastasis, Mastectomy, adverse effects, Middle Aged, Multivariate Analysis, Neoplasm Micrometastasis, Odds Ratio, Predictive Value of Tests, Proportional Hazards Models, Radiotherapy, Adjuvant, Retrospective Studies, Risk Factors, Sentinel Lymph Node Biopsy, Time Factors, Treatment Outcome, Triple Negative Breast Neoplasms, chemistry

Référence

Eur. J. Cancer. 2016 May;58:73-82